Equillium, Inc. Cash and Equivalents

Quick Answer

Equillium, Inc. reported Cash and Equivalents of $30.28 million for fiscal year 2025.

Equillium, Inc. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $30.28M +67.4%
2024 $18.09M -22.1%
2023 $23.22M -60.7%
2022 $59.11M +17.4%
2021 $50.37M +110.0%
2020 $23.98M +81.4%
2019 $13.22M -53.6%
2018 $28.51M +301.3%
2017 $7.10M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $33.12M +114.4% +188.1%
June 30, 2025 $11.49M +4.0% -20.7%
March 31, 2025 $14.50M +25.4% -19.8%
December 31, 2024 $18.09M -22.1% +17.1%
September 30, 2024 $15.45M -55.1% +39.7%
June 30, 2024 $11.06M -56.8% -4.4%
March 31, 2024 $11.57M -52.8% -50.2%
December 31, 2023 $23.22M -60.7% -32.5%
  • Equillium, Inc. showed an increase of +67.4% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2017–2025 period, Equillium, Inc.’s cash and equivalents has grown by 326.2% (from $7.10 million to $30.28 million).
  • The most recent figure is from Equillium, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment